Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.

Saved in:
Bibliographic Details
Title: Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.
Authors: Gosztonyi B; Department of Medical Oncology and Hematology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Mehra T; Department of Medical Oncology and Hematology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Gut G; Department of Medical Oncology and Hematology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Miglino N; Department of Medical Oncology and Hematology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Ring A; Department of Medical Oncology and Hematology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Martínez Gómez JM; Department of Dermatology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Ramelyte E; Department of Dermatology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Sobottka B; Department of Pathology and Molecular Pathology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland.; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Levesque MP; Department of Dermatology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Mangana J; Department of Dermatology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Dummer R; Department of Dermatology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland.; Department of Dermatology and Allergology, Kantonsspital Aarau, Aarau, Switzerland., Boos L; Department of Medical Oncology and Hematology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland., Wicki A; Department of Medical Oncology and Hematology, University Hospital Zurich, Medical Faculty, University of Zurich, Zurich, Switzerland.
Corporate Authors: Tumor Profiler Consortium
Source: JCO precision oncology [JCO Precis Oncol] 2026 Jan; Vol. 10 (1), pp. e2500896. Date of Electronic Publication: 2026 Feb 25.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2473-4284
DOI:10.1200/PO-25-00896